As Rollout Nears, Small Practices and Rural Clinics Anticipate Challenges Storing and Administering COVID-19 Vaccines
The much-awaited remedy to the widespread transmission of SARS-CoV-2 comes with many logistical caveats.
Allergy and Immunology Information Center
Vaccine Candidate AZD1222 Effective Against COVID-19
A total of 131 cases of COVID-19 were reported in the interim analysis, with no hospitalizations or severe cases noted in participants who received the vaccine.
Interim Data Show COVID-19 Vaccine Candidate mRNA-1273 Near 95% Effective
The placebo-controlled COVE study is investigating the efficacy and safety of mRNA-1273 at the 100mcg dose (given intramuscularly in a 2-dose series, approximately 28 days apart) in more than 30,000 adults aged 18 years and older.
COVID-19 Vaccine Candidate More Than 90% Effective, Say Pfizer, BioNTech
The trial will continue as planned and final analysis is expected when the number of confirmed COVID-19 cases reaches 164.
Nurse Practitioners Prevent Spread of Diseases Among Homeless Population Through Vaccine Program
Nurse practitioners (NPs) executed a 5-step vaccination program for homeless individuals in Miami-Dade County to help reduce the spread of infectious diseases.
COVID-19 Vaccine Allocation: Ethical Concerns, Practical Challenges
In the event of a likely scarcity of COVID-19 vaccines, a framework must be developed to inform who should get priority.
2018 to 2019 Vaccine Cut Influenza A-Linked Hospitalizations
The 2018 to 2019 influenza vaccine effectiveness was about 40% to 60% for reducing pediatric influenza A-associated hospitalizations.
Moderna: 30,000 Participants Enrolled in COVID-19 Vaccine Trial
The trial is investigating the efficacy, safety, and immunogenicity of mRNA-1273 at the 100mcg dose.
Novel Pneumococcal Conjugate Vaccine Immunogenic in Phase 3 Trials
Results from PNEU-PATH demonstrated comparable immune responses following vaccination with Pneumovax 23 in both treatment groups for the 15 serotypes in V114.
Survey Reveals Factors Contributing to COVID-19 Vaccine Acceptance
To estimate the association between attribute level and probability of choosing and receiving a vaccine, the study authors calculated the average marginal component effects sizes as well as marginal means.
Only Two-Thirds of Parents Planning to Get Flu Shots for Their Children
One-third of parents say they will forgo the flu vaccination for their children this year, despite public health recommendations.
FDA: Diphenhydramine Overdoses Linked to New Social Media Challenge
Diphenhydramine when taken at higher than recommended doses can lead to serious health complications.
ACIP Provides Recommendations on Meningococcal Vaccination
Routine vaccination with a quadrivalent meningococcal conjugate vaccine is recommended for adolescents aged 11 to 12 years.
COVID-19 Vaccines: AstraZeneca Resumes Trial; Pfizer, BioNTech Look to Expand Study
The Medicines Health Regulatory Authority confirmed that the AZD1222 trial could proceed after a UK committee concluded its investigations.
Single-Dose Nirsevimab Provides Season-Long RSV Protection for Preterm Infants
Single-dose nirsevimab successfully reduced rates of respiratory syncytial virus-associated lower respiratory infections and hospitalizations in pre-term infants.
Safety, Immunogenicity of Investigational Inactivated Whole-Virus COVID-19 Vaccine
An investigational inactivated whole-virus COVID-19 vaccine has demonstrated safety and immunogenicity, according to an interim analysis.
Underutilization of Influenza Vaccination in Populations at High-Risk for Complications
Influenza vaccinations were found to be underutilized among groups who are considered to be at high risk for complications from infection.
ACIP: Influenza Vaccination Recommendations for 2020-2021
Influenza vaccination should occur by the end of October, if possible.
HHS Authorizes Pharmacists to Administer Vaccines to Children
HHS issued the amendment in order to increase access to childhood vaccines and decrease the risk of vaccine-preventable disease outbreaks as children return to daycare and school.
Many Pediatric Practitioners Do Not Advise Waiting Between New Foods
Most pediatric practitioners do not counsel families to wait 3 days or longer between introducing new foods for infants.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Allergy and Immunology Information Center
